GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (BSP:R1VT34) » Definitions » Cyclically Adjusted Price-to-FCF

Revvity (BSP:R1VT34) Cyclically Adjusted Price-to-FCF : 23.63 (As of May. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Revvity Cyclically Adjusted Price-to-FCF?

As of today (2024-05-01), Revvity's current share price is R$18.67. Revvity's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$0.79. Revvity's Cyclically Adjusted Price-to-FCF for today is 23.63.

The historical rank and industry rank for Revvity's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BSP:R1VT34' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 19.25   Med: 35.86   Max: 64.63
Current: 22.92

During the past years, Revvity's highest Cyclically Adjusted Price-to-FCF was 64.63. The lowest was 19.25. And the median was 35.86.

BSP:R1VT34's Cyclically Adjusted Price-to-FCF is ranked better than
65.08% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.14 vs BSP:R1VT34: 22.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Revvity's adjusted free cash flow per share data for the three months ended in Mar. 2024 was R$0.187. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is R$0.79 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Revvity Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Revvity's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Cyclically Adjusted Price-to-FCF Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.73 53.77 52.65 31.74 24.64

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.43 26.77 25.24 24.64 23.48

Competitive Comparison of Revvity's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted Price-to-FCF falls into.



Revvity Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Revvity's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=18.67/0.79
=23.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Revvity's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.187/129.4194*129.4194
=0.187

Current CPI (Mar. 2024) = 129.4194.

Revvity Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.032 100.560 0.041
201409 0.040 100.428 0.052
201412 0.076 99.070 0.099
201503 0.033 99.621 0.043
201506 0.056 100.684 0.072
201509 0.065 100.392 0.084
201512 0.141 99.792 0.183
201603 0.029 100.470 0.037
201606 0.098 101.688 0.125
201609 0.069 101.861 0.088
201612 0.154 101.863 0.196
201703 0.048 102.862 0.060
201706 0.045 103.349 0.056
201709 0.048 104.136 0.060
201712 0.118 104.011 0.147
201803 -0.039 105.290 -0.048
201806 0.068 106.317 0.083
201809 0.095 106.507 0.115
201812 0.157 105.998 0.192
201903 -0.037 107.251 -0.045
201906 0.037 108.070 0.044
201909 0.119 108.329 0.142
201912 0.252 108.420 0.301
202003 0.062 108.902 0.074
202006 0.202 108.767 0.240
202009 0.328 109.815 0.387
202012 0.777 109.897 0.915
202103 0.821 111.754 0.951
202106 0.427 114.631 0.482
202109 0.474 115.734 0.530
202112 0.492 117.630 0.541
202203 0.360 121.301 0.384
202206 0.111 125.017 0.115
202209 0.217 125.227 0.224
202212 0.168 125.222 0.174
202303 0.063 127.348 0.064
202306 -0.206 128.729 -0.207
202309 -0.079 129.860 -0.079
202312 0.245 129.419 0.245
202403 0.187 129.419 0.187

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Revvity  (BSP:R1VT34) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Revvity Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Revvity's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (BSP:R1VT34) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity (BSP:R1VT34) Headlines

No Headlines